MedTrace Logo

Docetaxel and Ifosfamide in Treating Women With Metastatic Breast Cancer

NCT00026078 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2013-08-07

No results posted yet for this study

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

PURPOSE: Phase II trial to study the effectiveness of docetaxel and ifosfamide in treating women who have metastatic breast cancer.

Conditions

Interventions

DRUG

docetaxel

DRUG

ifosfamide

Sponsors & Collaborators

  • Grupo Oncologico Cooperativo del Sur

    lead OTHER

Principal Investigators

  • Bernardo A. Leone, MD · Unidad Oncologica Del Neuquen

Study Design

Purpose
TREATMENT

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-03-31

Countries

  • Argentina
  • Mexico

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00026078 on ClinicalTrials.gov